StageZero Life Sciences Ltd. (SZLSF) Financials

SZLSF Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 580747 11.7 million
June 30, 2024 583738 11.3 million
March 31, 2024 379074 10.6 million
Sept. 30, 2023 508422 9.6 million

SZLSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 10257 11893
June 30, 2024 -62921 11783
March 31, 2024 -92517 11944
Sept. 30, 2023 47816 261092

SZLSF Net Income

No data available :(

SZLSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 15032 873480 174113
June 30, 2024 20721 838354 216035
March 31, 2024 5530 759268 -
Sept. 30, 2023 24092 740976 -

SZLSF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 123.5 million
June 30, 2024 123.5 million
March 31, 2024 123.6 million
Sept. 30, 2023 123.5 million

SZLSF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 3 - 282523 15947
June 30, 2024 - - 703101 -
March 31, 2024 3 - 595778 26284
Sept. 30, 2023 - 19728 909419 -12660

SZLSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 499663 569262
June 30, 2024 390083 382265
March 31, 2024 519589 238584
Sept. 30, 2023 745488 577075

SZLSF

Price: $0

52 week price:
0.00
0.02

Earnings Per Share: -0.02 USD

Exchange: PNK

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 123532

Links: